Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Organ Transplantation | 8 | 2021 | 2616 | 1.32 | Why? |
| Tissue and Organ Procurement | 6 | 2021 | 1277 | 1.25 | Why? |
| Hepatitis C | 5 | 2019 | 1514 | 1.11 | Why? |
| Tissue Donors | 8 | 2021 | 1679 | 1.02 | Why? |
| Donor Selection | 3 | 2018 | 804 | 0.58 | Why? |
| Drug Users | 1 | 2018 | 234 | 0.57 | Why? |
| Substance Abuse, Intravenous | 1 | 2018 | 411 | 0.53 | Why? |
| Nucleic Acids | 1 | 2018 | 435 | 0.52 | Why? |
| North Carolina | 3 | 2021 | 571 | 0.40 | Why? |
| Perioperative Care | 1 | 2020 | 1329 | 0.38 | Why? |
| Hepacivirus | 4 | 2019 | 1509 | 0.37 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.35 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.35 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.33 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.29 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.24 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.19 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.19 | Why? |
| Uronic Acids | 1 | 2017 | 3 | 0.18 | Why? |
| Heart Transplantation | 2 | 2018 | 1293 | 0.17 | Why? |
| Saccharomycetales | 1 | 2018 | 118 | 0.17 | Why? |
| Mycobacterium abscessus | 1 | 2017 | 31 | 0.17 | Why? |
| Universities | 3 | 2021 | 4374 | 0.17 | Why? |
| United States Public Health Service | 1 | 2017 | 50 | 0.16 | Why? |
| Lung Transplantation | 2 | 2019 | 1554 | 0.16 | Why? |
| Aspergillus fumigatus | 1 | 2018 | 239 | 0.15 | Why? |
| Transplant Recipients | 4 | 2021 | 4982 | 0.15 | Why? |
| Purines | 1 | 2020 | 816 | 0.14 | Why? |
| Azetidines | 1 | 2020 | 722 | 0.14 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 167 | 0.14 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.13 | Why? |
| Program Development | 1 | 2020 | 1089 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.12 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.12 | Why? |
| Athletes | 1 | 2021 | 1047 | 0.12 | Why? |
| Sulfonamides | 1 | 2020 | 1294 | 0.11 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.11 | Why? |
| Advisory Committees | 1 | 2018 | 1418 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Preoperative Care | 1 | 2020 | 1515 | 0.10 | Why? |
| Pyrazoles | 1 | 2020 | 1791 | 0.10 | Why? |
| Waiting Lists | 1 | 2018 | 1388 | 0.10 | Why? |
| Postoperative Complications | 2 | 2020 | 5861 | 0.10 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.09 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.09 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Seroconversion | 1 | 2018 | 2515 | 0.09 | Why? |
| Humans | 22 | 2021 | 930598 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2019 | 3388 | 0.07 | Why? |
| Serologic Tests | 1 | 2019 | 4359 | 0.07 | Why? |
| Surgical Procedures, Operative | 1 | 2020 | 2662 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| United States | 6 | 2021 | 46150 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.05 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2017 | 207 | 0.04 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Sports | 1 | 2021 | 690 | 0.03 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.03 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Male | 7 | 2020 | 367725 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.02 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.02 | Why? |
| Female | 6 | 2020 | 380317 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Communication | 1 | 2017 | 5206 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Masks | 1 | 2021 | 8528 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Adult | 3 | 2020 | 244371 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Wolfe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(145)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_